GALNT16 and neoplasm: The results showed that the group with YY1 knockdown combined with anti‐PD‐1 treatment exhibited significant tumor growth inhibition, whereas the GALNT16 overexpression group showed accelerated tumor growth (Figures 7E, F and S4).